Tracked deals
5
5 tracked deals across 2023-2026.
Operating Company
Healthcare
VION Biosciences
Cleveland, Ohio, United States
VION Biosciences is a life science platform delivering manufacturing and mission-critical chemicals and specialty reagents alongside value-added services to enable scientific discovery, clinical testing, and therapeutic development across research to commercialization applications.
- Focus Areas
- Immunology immune monitoring, Immunodiagnostics, Immunoassays & assay development/manufacturing
- Website
- vionbiosciences.com
Recent pace
2
2 tracked deals announced in the last 12 months.
Deal mix
Buyout
3 buyout · 2 addon
VION Biosciences Acquisition Volume by Year
Last 3 years
Actual
Full-year estimate
Supporting Data
Recent Transactions
-
September 8, 2026
- Buyer
- VION Biosciences, Edgewater Capital Partners
- Target
- Prolytix
- Seller
- Edgewater Capital Partners
- Industry
- Biotechnology
- Location
- Ohio, United States
- Type
- Buyout
VION Biosciences announced the closing of its acquisition of Prolytix, a provider of regulated bioanalytical and CMC services, research reagents, and custom sample collection products. The deal is intended to strengthen VION’s integrated platform across biopharma services and diagnostic workflow inputs, including regulated large-molecule testing and workflow-critical reagents and IVD materials.
-
- Buyer
- VION Biosciences
- Target
- Cellular Technology Limited (CTL)
- Industry
- Healthcare Services
- Location
- Ohio, United States
- Type
- Buyout
VION Biosciences has completed its acquisition of Cellular Technology Limited (CTL), a provider of functional immune monitoring analyzers, software, consumables, and services. The deal strengthens VION’s workflow-oriented immune medicine capabilities by adding CTL’s ELISPOT/FluoroSpot platforms, regulatory-grade software, and an established global installed base.
-
August 29, 2024
- Buyer
- VION Biosciences, Iron Path Capital
- Target
- Ansh Labs
- Industry
- Biotechnology
- Location
- Texas, United States
- Type
- Addon
VION Biosciences, the life-science platform backed by Iron Path Capital, has acquired Ansh Labs, an immunoassay development and reagent manufacturer based in Houston, Texas. The add-on expands VION's diagnostics capabilities — adding GMP IVD manufacturing and ISO 13485 certification — and broadens the platform's product and service offerings for clinical diagnostics, research, and pharmaceutical development.
-
August 22, 2024
- Buyer
- VION Biosciences, Iron Path Capital
- Target
- Echelon Biosciences
- Seller
- Bert V. Israelsen
- Industry
- Biotechnology
- Location
- Utah, United States
- Type
- Addon
VION Biosciences, the life-science platform backed by Iron Path Capital, has acquired Salt Lake City-based Echelon Biosciences, a specialist supplier of lipid-based excipients and lipid nanoparticles. The add-on strengthens VION's capabilities in lipid synthesis and lipid nanoparticle technology to support mRNA and gene-therapy development and advances the platform toward drug manufacturing while keeping Echelon’s leadership and operations intact.
-
- Buyer
- VION Biosciences, Iron Path Capital
- Target
- Aldon Corporation
- Industry
- Manufacturing
- Location
- New York, United States
- Type
- Buyout
Iron Path Capital has formed VION Biosciences as a life-science roll-up platform and completed the acquisition of Aldon Corporation, a private-label manufacturer and distributor of lab chemicals headquartered in Avon, New York. Aldon will serve as VION’s inaugural platform investment to build a specialty chemicals and reagents business serving biopharma, molecular diagnostics and STEM education markets; Mark Thornton was named CEO of VION Biosciences.
Related Acquisition Pages
Biotechnology Buyers & Acquisitions
3 tracked deals by VION Biosciences.
Healthcare Services Buyers & Acquisitions
1 tracked deal by VION Biosciences.
Manufacturing Buyers & Acquisitions
1 tracked deal by VION Biosciences.
Acquisitions in Ohio
2 tracked deals by VION Biosciences.
Acquisitions in New York
1 tracked deal by VION Biosciences.
Acquisitions in Texas
1 tracked deal by VION Biosciences.
Acquisitions in Utah
1 tracked deal by VION Biosciences.
Selling a company? Get in front of buyers like VION Biosciences
Turn tracked acquisition activity into an outreach-ready buyer list.